Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2025-12-31 @ 11:14 PM
Study NCT ID:
NCT04140305
Status:
TERMINATED
Last Update Posted:
2025-06-12
First Post:
2019-10-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-16
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-15
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-24
First Submit QC Date:
None
Study First Post Date:
2019-10-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-09
Last Update Post Date:
2025-06-12
Last Update Post Date Type:
ACTUAL